Passions

Travelling

Legos

Experience

Reata Closes $275M Debt Financing and Amendment of its Development Funding Agreement

May 5, 2023

Cooley advised Reata Pharmaceuticals on a $275 million debt financing from funds managed by Pharmakon Advisors, and on an amendment and restatement of its development and commercialization funding agreement with affiliates of Blackstone Life Sciences. Reata – a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases –trades on the Nasdaq Global Market under the symbol RETA. Lawyers Michael Tollini, Mischi a Marca, Addison Pierce, Kelsey Watkins and Xueqing Li led the Cooley team.

Related contacts

Michael Tollini
Partner, Washington DC
Mischi a Marca
Partner, San Francisco
Addison Pierce
Associate, Chicago
Kelsey Watkins
Associate, Chicago
Xueqing Li
Associate, San Francisco

Related Practices & Industries

Fernweh to Acquire Controlling Interest in AZZ Infrastructure Solutions Segment

July 23, 2022

Cooley advised affiliates of Fernweh Group on its definitive agreement with AZZ. Lawyers Ian Nussbaum and Bill Roegge led the Cooley team advising Fernweh.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Bill Roegge
Partner, New York
Maya Rahwanji
Associate, New York
Patricia Myers
Paralegal Specialist, Colorado
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
David Walsh
Partner, Reston
Paula Fleckenstein
Associate, Reston
Stacey A. Bradford
Special Counsel, Washington DC
Ryan Vann
Partner, Chicago
Miriam Petrillo
Special Counsel, Chicago
Charles Haley
Partner, Palo Alto
David H. Zhou
Associate, Palo Alto
Michelle Zhou
Associate, Palo Alto
Caitlin Courtney
Associate, Palo Alto
Lei Shen
Partner, Chicago
Christian Lee
Associate, San Francisco
Christopher Kimball
Partner, Washington DC
Bridget R. Reineking
Special Counsel, Washington DC
Annie Froehlich
Special Counsel, Washington DC
Rebecca Ross
Special Counsel, Washington DC
Dillon Martinson
Special Counsel, Washington DC
Grant Schweikert
Special Counsel, Washington DC
Peter Crain
Special Counsel, Reston
Jacqueline Grise
Partner, Washington DC
Stella Sarma
Special Counsel, Brussels
Richard G.S. Lee
Associate, Washington DC
Patrick Flanagan
Partner, New York
Maria Cornilsen
Special Counsel, New York
Alexandra Leavy
Associate, New York
Xueqing Li
Associate, San Francisco
Kathleen Goodhart
Partner, San Francisco
Rachel F. Katz
Associate, New York
Rachel F. Katz
Associate, New York

Related Practices & Industries

Vera Therapeutics Closes $50 Million Debt Financing

December 18, 2021

Cooley advised Vera Therapeutics on its $50 Million debt facility with Oxford Finance. Vera, whose shares trade on the Nasdaq Global Market under the symbol VERA, is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Partner Patrick Flanagan led the Cooley team.

Related contacts

Patrick Flanagan
Partner, New York
Addison Pierce
Associate, Chicago
Xueqing Li
Associate, San Francisco

Related Practices & Industries

Dynavax Technologies – $200 Million Convertible Notes Offering

May 11, 2021

Cooley advised Dynavax Technologies on its offering of $200 million principal amount of 2.50% convertible senior notes due 2026. Dynavax Technologies, whose securities trade on the Nasdaq Capital Market under the symbol DVAX, is a biopharmaceutical company focused on developing and commercializing novel vaccines. Partners Steve Przesmicki, Mischi a Marca and Jason Savich le the Cooley team.

Related contacts

Steve Przesmicki
Partner, San Diego
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Marina Remennik
Special Counsel, Palo Alto
Megan Ji
Associate, Seattle
Ron Metzger
Paralegal Specialist, San Francisco
Ellie Guadiana
Partner, Los Angeles Santa Monica
Matt Kong
Associate, San Francisco
Xueqing Li
Associate, San Francisco
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries